|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
535 W 24th St, 5th Floor, New York, New York 10011, US
|
|
Neurogene is accelerating development of new genetic medicines to people with devastating neurological diseases and their families. To do this, we are working with experts across the globe to advance a broad pipeline of programs to treat the underlying cause of serious neurological disorders and thereby address the overwhelming need for new therapies.
Although the human genome was sequenced for the first time nearly 20 years ago, the true genomics revolution is taking place now, providing us with the ability to radically alter rare, genetic disorders. At Neurogene, we are working to provide medicines to improve the lives of neurologically-impaired and developmentally-delayed children and their families.
We are building a team of passionate, driven individuals who envision a world in which all families have access to genetic medicines, even if the disorder is exceedingly rare.
To learn more, please visit http://www.neurogene.com/careers/.
|
Neurogene Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Neurogene Inc. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Neurogene Inc. customer service number in your country click here to find.
Rachel Mcminn is the CEO of Neurogene Inc.. To contact Rachel Mcminn email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.